These same types of modifications (fatty acid chains, albumin binding) that work for pure GLP-1 agonists also extend tirzepatides duration
Both are produced to pharmaceutical standards from licensed facilities
Clinical trial context: According to the manufacturer, the STEP 1 trial demonstrated 14.9% average body weight loss over 68 weeks among participants who also followed reduced-calorie diets and increased physical activity
The opportunity for an oral GLP-1 medication with highly effective weight loss that is simpler to take may provide increased access and opportunities for better health for our patients with obesity and diabetes, said Deborah Horn, DO, MPH, professor and director of obesity medicine at McGovern Medical School at UTHealth Houston and principal author of the study
Store the reconstituted vial in the refrigerator at 2 to 8C Do not store in the freezer Discard after 30 days from reconstitution Wipe the rubber stopper with an alcohol swab before each draw Monitoring and Side Effects Track the following daily, especially during Phase 1: appetite changes, energy levels, and any injection site reactions
Knowing a genotype in these pathways does not guarantee faster or greater weight loss and does not select a medication or a dose
